1. Home
  2. ICUI vs PBH Comparison

ICUI vs PBH Comparison

Compare ICUI & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • PBH
  • Stock Information
  • Founded
  • ICUI 1984
  • PBH 1996
  • Country
  • ICUI United States
  • PBH United States
  • Employees
  • ICUI N/A
  • PBH N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • PBH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICUI Health Care
  • PBH Health Care
  • Exchange
  • ICUI Nasdaq
  • PBH Nasdaq
  • Market Cap
  • ICUI 3.2B
  • PBH 3.3B
  • IPO Year
  • ICUI 1992
  • PBH 2005
  • Fundamental
  • Price
  • ICUI $140.16
  • PBH $59.95
  • Analyst Decision
  • ICUI Buy
  • PBH Buy
  • Analyst Count
  • ICUI 6
  • PBH 5
  • Target Price
  • ICUI $183.60
  • PBH $86.40
  • AVG Volume (30 Days)
  • ICUI 290.1K
  • PBH 410.8K
  • Earning Date
  • ICUI 11-06-2025
  • PBH 11-06-2025
  • Dividend Yield
  • ICUI N/A
  • PBH N/A
  • EPS Growth
  • ICUI N/A
  • PBH N/A
  • EPS
  • ICUI N/A
  • PBH 4.04
  • Revenue
  • ICUI $2,320,363,000.00
  • PBH $1,110,479,000.00
  • Revenue This Year
  • ICUI N/A
  • PBH N/A
  • Revenue Next Year
  • ICUI N/A
  • PBH $2.69
  • P/E Ratio
  • ICUI N/A
  • PBH $14.83
  • Revenue Growth
  • ICUI N/A
  • PBH N/A
  • 52 Week Low
  • ICUI $107.00
  • PBH $59.51
  • 52 Week High
  • ICUI $196.26
  • PBH $90.04
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 73.86
  • PBH 39.29
  • Support Level
  • ICUI $116.21
  • PBH $59.51
  • Resistance Level
  • ICUI $120.60
  • PBH $63.56
  • Average True Range (ATR)
  • ICUI 4.88
  • PBH 1.36
  • MACD
  • ICUI 1.92
  • PBH 0.04
  • Stochastic Oscillator
  • ICUI 69.73
  • PBH 15.80

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Share on Social Networks: